7/28/2019 Lecture - Three (Pharma Marketing)
1/44
Company
LOGO Pharmaceutical marketing
7/28/2019 Lecture - Three (Pharma Marketing)
2/44
Company name
Pharmaceutical Marketing
Identification of Market
Seller & Buyer
Pharmaceutical Companies
Government & government agencies Doctors Community
Public & Private Institutions and NGOs
Regional Distributors
Institutional Suppliers
Wholesale & Chain Pharmacies
Retail Pharmacies
Patients or Consumers
Export Business
7/28/2019 Lecture - Three (Pharma Marketing)
3/44
Company name
Identification of Market
7/28/2019 Lecture - Three (Pharma Marketing)
4/44
Company name
Identification of Market
7/28/2019 Lecture - Three (Pharma Marketing)
5/44
Company name
Identification of Market
7/28/2019 Lecture - Three (Pharma Marketing)
6/44
Company name
Identification of Market
7/28/2019 Lecture - Three (Pharma Marketing)
7/44
Company name
Identification of Market
7/28/2019 Lecture - Three (Pharma Marketing)
8/44
Company name
Physician Prescribing Behavior
Physician Prescribing Behavior:
Patient with disease
Diagnosis of problem or Disease
Available Treatment options
Information of drugs
Faith & Confidence on particular drug
Prescription habits of doctor
Scientific information of drug
Doctors categories (Consultant, Family Physician,RMO etc.)
7/28/2019 Lecture - Three (Pharma Marketing)
9/44
Company name
Physician Prescribing Behavior
Physician Prescribing Behavior:
Branded vs Mee too Products prescriptions
Reach & Frequency of Pharma Companies
Stages of prescription behavior
1. Unaware
2. Aware
3. Accept4. Test
5. Prescribe
6. Choice of drug
7/28/2019 Lecture - Three (Pharma Marketing)
10/44
Company name
Physician Prescribing Behavior
7/28/2019 Lecture - Three (Pharma Marketing)
11/44
Company name
Physician Prescribing Behavior
7/28/2019 Lecture - Three (Pharma Marketing)
12/44
Company name
Physician Prescribing Behavior
7/28/2019 Lecture - Three (Pharma Marketing)
13/44
Company name
Physician Prescribing Behavior
7/28/2019 Lecture - Three (Pharma Marketing)
14/44
Company name
Physician Relations.
The report suggests a range of ways social networks can beused, including for market research, physician relations,
clinical trials and medical education
7/28/2019 Lecture - Three (Pharma Marketing)
15/44
Company name
Patient Motivation
Patient Motivation: Change from Normal occurred
Significance of the change
Need for Help
Need immediate relief
Proper diagnosis
Need thorough Counseling
Need of effective drugDosage Compliance
Economic Compliance
Legal Compliance
7/28/2019 Lecture - Three (Pharma Marketing)
16/44
Company name
Patient Motivation
7/28/2019 Lecture - Three (Pharma Marketing)
17/44
Company name
Patient Motivation
7/28/2019 Lecture - Three (Pharma Marketing)
18/44
Company name
Patient Motivation
7/28/2019 Lecture - Three (Pharma Marketing)
19/44
Company name
Market Analysis
Market Analysis: Measurement of market for any drug
Market Research
Primary Research
Patient surveys Doctors opinions
Focus Group Surveys
Retail & Wholesale Audits
Institutional Purchase Audit
Secondary Research
Published Periodic data
Other Sources
7/28/2019 Lecture - Three (Pharma Marketing)
20/44
Company name
Market Analysis
7/28/2019 Lecture - Three (Pharma Marketing)
21/44
Company name
Market Analysis
7/28/2019 Lecture - Three (Pharma Marketing)
22/44
Company name
Market Analysis
7/28/2019 Lecture - Three (Pharma Marketing)
23/44
Company name
Development Stages
Development Stages of New Product:
Product Exploration
Product Screening
Product Business Analysis
Product Research & Development
Product Testing
Product Commercialization
7/28/2019 Lecture - Three (Pharma Marketing)
24/44
Company name
Development Stages of new Drug
7/28/2019 Lecture - Three (Pharma Marketing)
25/44
Company name
Stages of Development
7/28/2019 Lecture - Three (Pharma Marketing)
26/44
Company name
Birth of a New Drug or Product
Birth of a Product or Drug:
Development of the new drug
Investigational New Drugs (IND)
Preparation of new drug application (NDA)
Submission of the new NDA
New drug application approval
Development of Manufacturing Processes
Registration of drug from Regulatory Authorities
Acceptance & Commercialization
7/28/2019 Lecture - Three (Pharma Marketing)
27/44
Company name
Birth of a New Drug
7/28/2019 Lecture - Three (Pharma Marketing)
28/44
Company name
Birth of a New Drug
7/28/2019 Lecture - Three (Pharma Marketing)
29/44
Company name
New drug development
7/28/2019 Lecture - Three (Pharma Marketing)
30/44
Company name
Product development Process
7/28/2019 Lecture - Three (Pharma Marketing)
31/44
Company name
R&D & Launch of Pharma Product
Diversification & Specialization in Pharam drugs1. Specialization in a particular therapeutic area
2. Specialization in different therapeutic area simultaneously
R&D of Product
In vivo & In vitro TrialsDefinition:
In vivo refers to a medical test, experiment or procedurethat is done on a living organism, such as a laboratoryanimal or human.
A study done in vivo looks at how the body responds to aparticular substance, in contrast to in vitro studies that aredone in a test tube or laboratory dish.
http://lungcancer.about.com/od/glossary/g/invitro.htmhttp://lungcancer.about.com/od/glossary/g/invitro.htm7/28/2019 Lecture - Three (Pharma Marketing)
32/44
Company name
Steps Involved in R&D Process
Research and Development of pharmaceutical products take a lengthy periodthat spans over ten years and requires large investment.
Prior to market launch, new drugs undergo a long and complicated series of
steps, including an evaluation of efficacy and safety, application for approval,
and investigation and approval of drug applications by regulatory authorities.
7/28/2019 Lecture - Three (Pharma Marketing)
33/44
Company name
Product Development
7/28/2019 Lecture - Three (Pharma Marketing)
34/44
Company name
In Vitro vs. In Vivo
7/28/2019 Lecture - Three (Pharma Marketing)
35/44
Company name
Drug Development Pipeline
7/28/2019 Lecture - Three (Pharma Marketing)
36/44
Company name
Pharmaceutical Marketing
7/28/2019 Lecture - Three (Pharma Marketing)
37/44
Company name
In vitro & In Vivo
7/28/2019 Lecture - Three (Pharma Marketing)
38/44
Company name
R&D & Launch of Pharma Product
7/28/2019 Lecture - Three (Pharma Marketing)
39/44
Company name
R&D & Launch of Pharma Product
Definition: In vivo refers to a medical test, experiment or
procedure that is done on a living organism, suchas a laboratory animal or human.
A study done in vivo looks at how the bodyresponds to a particular substance, in contrastto in vitro studies that are done in a test tube orlaboratory dish.
Multicenter Trials
Regulatory Bodies (DRA, PPMA, MoH, FDA etc.)
http://lungcancer.about.com/od/glossary/g/invitro.htmhttp://lungcancer.about.com/od/glossary/g/invitro.htm7/28/2019 Lecture - Three (Pharma Marketing)
40/44
Company name
Product development Process
7/28/2019 Lecture - Three (Pharma Marketing)
41/44
Company name
Steps Involved in R&D Process
7/28/2019 Lecture - Three (Pharma Marketing)
42/44
Company name
Phases of drug development
7/28/2019 Lecture - Three (Pharma Marketing)
43/44
Company name
Drug Registration
7/28/2019 Lecture - Three (Pharma Marketing)
44/44
Company name
THANK YOU FOR
ATTENTION!
Q&A
Top Related